As users increasingly interact with voice-first AI assistants, the traditional digital advertising model faces a major disruption. With no screen to display ads, companies that rely on visual ad revenue, like Google, must find new ways to monetize these interactions without ruining the user experience.

Instead of charging doctors for its valuable productivity tools, Doximity offers them for free to maximize user engagement. This creates a highly concentrated, valuable audience of physicians, which is then monetized through targeted advertising from pharmaceutical companies, its primary revenue source.

As ad platforms like Google automate bid management, an agency's value is no longer in manual "button pushing." The new competitive edge is the ability to feed the platform's AI with superior client data and insights. Agencies that cannot access and leverage this data will struggle to demonstrate value.

The pharmaceutical industry is often misunderstood because it communicates through faceless corporate entities. It could learn from tech's "go direct" strategy, where leaders tell compelling stories. Highlighting the scientists and patient journeys behind breakthroughs could dramatically improve public perception and appreciation.

Leaders often choose expensive, traditional advertising for ego gratification, like a TV spot during a baseball game, over more effective and profitable digital platforms. This preference for the familiar methods of 'yesterday' stifles growth and wastes money in favor of personal validation.

Instead of treating all channels equally, identify which customer segments (e.g., brand advertisers) are best served by which channels (e.g., TV screens). Shifting demand accordingly can unlock massive growth by optimizing the entire portfolio and increasing customer ROI.

While digital advertising constitutes 75% of spend in the general economy, it's only about half that in healthcare. This lag, driven by an entrenched reliance on in-person sales reps, creates a long-term secular tailwind for platforms like Doximity as the industry inevitably shifts its marketing budget online.

Doximity's product development is 'unapologetically' focused on increasing doctor productivity and saving them time. This user-centric approach builds deep engagement and trust, creating the highly valuable physician audience that forms the foundation of its advertising-based business model.

Unlike incumbents, new biotech and pharma companies often lack established sales forces. They launch with a 'digital first' go-to-market strategy, turning to platforms like Doximity early in their lifecycle. This creates a new and rapidly growing customer segment for Doximity, independent of the incumbents' slower transition.